Iris Morr
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Radiopharmaceutical Chemistry and Applications 7
- Medical Imaging Techniques and Applications 5
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Uwe Haberkorn (11 shared papers)Annette Altmann (10 shared papers)GERHARD VAN KAICK (9 shared papers)Franz Oberdorfer (6 shared papers)Shiming Jiang (3 shared papers)Uwe Haberkorn (3 shared papers)J. Blatter (3 shared papers)Matthias Erich Bellemann (3 shared papers)
In The Last Decade
Iris Morr
14 papers receiving 525 citations
Peers
Comparison fields: 5 of 47
- Radiology, Nuclear Medicine and Imaging 380
- Cancer Research 49
- Genetics 102
- Genetics 26
- Endocrinology, Diabetes and Metabolism 34
Countries citing papers authored by Iris Morr
This map shows the geographic impact of Iris Morr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Morr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Morr more than expected).
Fields of papers citing papers by Iris Morr
This network shows the impact of papers produced by Iris Morr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Morr. The network helps show where Iris Morr may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Morr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. | 2001 | 96 |
| 2 | Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. | 1996 | 81 |
| 3 | Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. | 1997 | 63 |
| 4 | Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. | 1994 | 52 |
| 5 | PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. | 1997 | 45 |
| 6 | 1998 | 42 | |
| 7 | 2001 | 36 | |
| 8 | 1998 | 29 | |
| 9 | 2001 | 27 | |
| 10 | Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir. | 1997 | 23 |
| 11 | 2001 | 23 | |
| 12 | 1996 | 18 | |
| 13 | 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene. | 1998 | 13 |
| 14 | 1998 | 4 |
About Iris Morr
Iris Morr is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research, Genetics, Endocrinology, Diabetes and Metabolism and Biotechnology, having authored 14 papers that have together received 552 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (7 papers), Virus-based gene therapy research (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Medical Imaging Techniques and Applications (5 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Drug Transport and Resistance Mechanisms (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (380 citations), Cancer Research (49 citations), Genetics (102 citations), Genetics (26 citations) and Endocrinology, Diabetes and Metabolism (34 citations). Iris Morr has collaborated with scholars based in Germany and Austria. Frequent co-authors include Uwe Haberkorn, Annette Altmann, GERHARD VAN KAICK, Franz Oberdorfer, Shiming Jiang, Uwe Haberkorn, J. Blatter, Matthias Erich Bellemann, Marcus Henze and Gunnar Brix. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Gene Therapy, Magnetic Resonance in Medicine, Nuclear Medicine and Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.